Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P516: Serological biomarkers of tissue remodeling are associated with endoscopic remission in Crohn’s disease patients treated with GED-0301 (mongersen)ECCO'21 Virtual
Year: 2021
Authors: Mortensen, J.(1);Feagan, B.(2);Bay-Jensen, A.C.(1);Karsdal, M.A.(1);Horan, G.(3);Harris, S.(4);Usikin, K.(3);
(1)Nordic Bioscience A/S, Biomarkers & Research, Herlev, Denmark;(2)Alimentiv, Clinical Trials, San Diego, United States;(3)Bristol-Myers Squibb, Translational Medicine, Princeton, United States;(4)Bristol-Myers Squibb, Translational Medicine, San Diego, United States
P517: One year effectiveness and safety of ustekinumab in Ulcerative Colitis: a multicentre real-world study from Italy.ECCO'21 Virtual
Year: 2021
Authors: Chiappetta, M.F.(1);Viola, A.(1);Mastronardi, M.(2);Turchini, L.(3);Carparellli , S.(4);Orlando, A.(5);Biscaglia , G.(4);Miranda , A.(6);Guida, L.(7);Costantino, G.(1);Scaldaferri, F.(8);Bossa, F.(4);Renna, S.(5);Cappello , M.(7);Orlando , A.(5);Armuzzi, A.(3);Fries, W.(1);
(1)University of Messina, IBD-unit- Dept. of Clinical and Experimental Medicine, Messina, Italy;(2)IRCCS 'De Bellis' Castellana Grotte, IBD-unit, Bari, Italy;(3)Fondazione Policlinico Universitario A. Gemelli IRCCS, CEMAD Digestive Disease Center, Rome, Italy;(4)Ospedale Casa Sollievo della Sofferenza IRCCS, U.O.C. di Gastroenterologia ed Endoscopia Digestiva, San Giovanni Rotondo, Italy;(5)A.O.O.R. “Villa Sofia-Cervello”, Inflammatory Bowel Disease Unit, Palermo, Italy;(6)A.U.O Policlinico di Napoli 'L. Vanvitelli', Gastroenterologia ed Endoscopia Digestiva, Napoli, Italy;(7)Policlinico Universitario Paolo Giaccone, Section of Gastroenterology and Hepatology- PROMISE, Palermo, Italy;(8)Fondazione Policlinico Universitario A. Gemelli IRCCS, CEMAD Digestive Disease Center-, Roma, Italy
P518: Compliance with Faecal calprotectin home testing as standard during COVID-19 pandemic compared to laboratory based testing pre-COVID.ECCO'21 Virtual
Year: 2021
Authors: Edwards, D.(1);Ibrahim, M.(2);Cooney, R.(2);Boulton, R.(2);
(1)University of Birmingham, Medical school, Birmingham, United Kingdom;(2)University Hospitals Birmingham, Gastroenterology, Birmingham, United Kingdom
P519: Impact of skin examination prior to initiation of biological treatment in patients with Inflammatory Bowel Disease: preliminary dataECCO'21 Virtual
Year: 2021
Authors: Hartl, C.(1);Novacek, G.(2);Reinisch, S.(2);Saciri, A.(1);Reinisch, W.(2);Primas, C.(2);Maier, H.(1);
(1)MedUni Vienna / Vienna General Hospital, Department of Dermatology, Vienna, Austria;(2)MedUni Vienna / Vienna General Hospital, Department of Gastroenterology, Vienna, Austria; Austrian IBD study group (ATISG)
P520: ‘Eetscore’ in patients with Inflammatory Bowel Disease: an online tool to assess diet quality and provide personalised dietary adviceECCO'21 Virtual
Year: 2021
Authors: Lamers, C.R.(1,2);van Erp, L.W.(3);Slotegraaf, A.I.(2);Groenen, M.J.M.(3);de Roos, N.M.(2);Wahab, P.J.(3);Witteman, B.J.M.(1,2);
(1)Hospital Gelderse Vallei, Gastroenterology and Hepatology, Ede, The Netherlands;(2)Wageningen University & Research, Human Nutrition and Health, Wageningen, The Netherlands;(3)Rijnstate Hospital, Gastroenterology and Hepatology, Arnhem, The Netherlands
P521: Correlation between physician disease assessment in Ulcerative Colitis and burden of disease: ICONIC 2-year data of 120 patients in TurkeyECCO'21 Virtual
Year: 2021
Authors: Sezgin, O.(1);Atug, O.(2);Gonen, C.(3);Can, G.(4);Duman, A.E.(5);Erzin, Y.Z.(6);Yurci, M.A.(7);Alkim, C.(8);Unal Ozcelik, N.G.(9);Yildirim, B.(10);Kayacetin, E.(11);Beyazit, Y.(12);Tayfur Yurekli, O.(11);Kiyici, M.(13);
(1)Mersin University - Faculty of Medicine Department of General Surgery, Department of Gastroenterology, Mersin, Turkey;(2)Marmara University Medical Faculty Training and Research Hospital, Institute of Gastroenterology, Istanbul, Turkey;(3)Acibadem Mehmet Ali Aydinlar University- School of Medicine, Department of Gastroenterology, Istanbul, Turkey;(4)Bolu Abant İzzet Baysal University İzzet Baysal Training and Research Hospital- School of Medicine, Department of Gastroenterology, Bolu, Turkey;(5)Kocaeli University- School of Medicine, Department of Gastroenterology, Kocaeli, Turkey;(6)Istanbul University-Cerrahpasa, Department of Gastroenterology, Istanbul, Turkey;(7)Erciyes University- School of Medicine, Department of Gastroenterology, Kayseri, Turkey;(8)Sisli Hamidiye Etfal Training and Research Hospital, Department of Gastroenterology, Istanbul, Turkey;(9)Ege University Medical Faculty Hospital, Department of Gastroenterology, İzmir, Turkey;(10)Ondokuz Mayıs University- School of Medicine, Department of Gastroenterology, Samsun, Turkey;(11)Ankara City Hospital, Department of Gastroenterology, Ankara, Turkey;(12)Canakkale 18 Mart University Health Research and Application Center, Department of Gastroenterology, Canakkale, Turkey;(13)Uludag University- School of Medicine, Department of Gastroenterology, Bursa, Turkey
P522: Effectiveness of tofacitinib in a real-world Israeli cohort of patients with moderate-severe ulcerative colitisECCO'21 Virtual
Year: 2021
Authors: Avni Biron, I.(1);Bar-Gil Shitrit , A.(2);Koslowsky, B.(2);Kopylov, U.(3);Levartovsky, A.(3);Weisshof, R.(4);Aviv-Cohen, N.(5);Maharshak, N.(5);Hovel, D.(6);Naftali, T.(7);Goren, I.(1);Snir, I.(1);ollech, J.(1);Banai, H.(1);Lena, B.(1);Dotan, I.(1);Yanai, H.(1);
(1)Rabin Medical Center - Beilinson Hospital, Department of Gastroenterology, Petah Tikva, Israel;(2)Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel;(3)Sheba Medical Center, Department of Gastroenterology and Liver Diseases, Ramat-Gan, Israel;(4)Rambam Health Care Campus, Gastroenterology Institute, Haifa, Israel;(5)Tel Aviv Medical Center, IBD Center- Department of Gastroenterology and Liver Diseases, Tel-Aviv, Israel;(6)Edith Wolfson Medical Center, Department of Gastroenterology and Liver Diseases, Holon, Israel;(7)Meir Medical Center, Department of Gastroenterology and Liver Diseases, Kfar-sava, Israel
P523: Survey to identify patient characteristics, treatment preferences and impact of inflammatory bowel disease (IBD) on quality of life across 7 countries in EuropeECCO'21 Virtual
Year: 2021
Authors: Fiorino, G.(1);Bent-Ennakhil, N.(2);Varriale, P.(3);Braegger, F.(2);Hoefkens, E.(4);
(1)Humanitas Research Hospital, IBD Center- Gastroenterology, Rozzano, Italy;(2)Takeda Pharmaceuticals International AG, Glattpark-Opfikon, Opfikon, Switzerland;(3)Carenity- 1 Rue de Stockholm, Carenity- 1 Rue de Stockholm, Paris, France;(4)Imelda Hospital, Imelda Hospital, Bonheiden, Belgium
P524: Endoscopic dilations of intestinal stenosis in Crohn's diseaseECCO'21 Virtual
Year: 2021
Authors: Badre, W.(1);Bahlaoui, O.(1);El Rhaoussi, F.Z.(1);Tahiri, M.(1);Haddad, F.(1);Hliwa, W.(1);
(1)CHU Ibn Rochd, hepato-gastro-enterology, Casablanca, Morocco
P525: Patients' Perception of Risks of biologic therapy During Covid-19 Pandemic in Israel Orly Lior, Ilia Sergeev, Nahum Ruhimovich, Michal Openheim, Fabiana Benjaminov, Dan Feldman, Yehuda Ringel, Timna Naftali Division of Gastroenterology and Liver Diseases, Meir Medical Center, Kfar Saba, IsraelECCO'21 Virtual
Year: 2021
Authors: Lior, O.(1);Sergeev, I.(1);Ruhimovich, N.(1);Openheim, M.(1);Benjaminov, F.(1);Feldman, D.(1);Ringel, Y.(1);Naftali, T.(1);
(1)'Meir Medical Center', Gastroenterology, Kfar Saba, Israel
P526: Social functioning, work-productivity and psychological assessment in a cohort of patients with inflammatory bowel disease: an observational studyECCO'21 Virtual
Year: 2021
Authors: Todeschini, A.(1);
(1)Policlinico di Bari, U.O. Gastroenterologia Universitaria, BARI, Italy; Todeschini A Contaldo A Ierardi E Di Leo A & Principi M
P527: Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn’s disease from a Belgian registryECCO'21 Virtual
Year: 2021
Authors: Louis , E.(1);Muls , V.(20);Bossuyt , P.(2);Colard , A.(3);Nakad , A.(4);Baert , D.(5);Mana , F.(6);Caenepeel , P.(7);Vanden Branden , S.(8);Vermeire , S.(9);D'Heygere , F.(10);Strubbe , B.(11);Cremer , A.(12);Setakhr , V.(13);Baert , F.(14);Vijverman , A.(15);Coenegrachts , J.L.(16);Flamme , F.(17);Hantson , A.(18);Bennett , D.(19);Van Gassen , G.(18);Hantsbarger , G.(19);
(1)University Hospital CHU of Liège, Department of Gastroenterology, Liège, Belgium;(2)Imeldaziekenhuis, Department of Gastroenterology, Bonheiden, Belgium;(3)Hospital CHC, Department of Gastroenterology, Liège, Belgium;(4)CHwapi Notre Dame, Department of Gastroenterology, Tournai, Belgium;(5)Maria Middelares Hospital, Department of Gastroenterology, Ghent, Belgium;(6)Clinique St. Jean, Department of Gastroenterology, Brussels, Belgium;(7)Ziekenhuis Oost Limburg, Department of Gastroenterology, Genk, Belgium;(8)Onze Lieve Vrouwziekenhuis, Department of Gastroenterology, Aalst, Belgium;(9)University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium;(10)AZ Groeninge Hospital, Department of Gastroenterology, Kortrijk, Belgium;(11)AZ St Lucas, Department of Gastroenterology, Gent, Belgium;(12)Hopital Universitaire Erasme, Department of Gastroenterology, Brussels, Belgium;(13)CHU UCL Namur site Sainte Elisabeth, Department of Gastroenterology, Brussels, Belgium;(14)AZ Delta, Department of Gastroenterology, Roeselare, Belgium;(15)Hospital CHR de la Citadelle, Department of Gastroenterology, Liège, Belgium;(16)Jessa Ziekenhuis- Hasselt, Department of Gastroenterology, Hasselt, Belgium;(17)CHU Ambroise Paré, Department of Gastroenterology, Mons, Belgium;(18)Takeda, Department of Gastroenterology, Brussels, Belgium;(19)Takeda, Department of Gastroenterology, Cambridge, United States;(20)SaintPierre University Hospital, Department of Gastroenterology, Brussels, Belgium
P528: Reducing intravenous monoclonal antibody observation times without compromising patient safety; a single-centre observational study.ECCO'21 Virtual
Year: 2021
Authors: Rees, F.(1);Packham, A.(1);Parmar, A.(1);Hills, E.(1);Smith, M.(1);St. Clair Jones, A.(1);
(1)Brighton & Sussex University Hospitals, IBD Team- Gastroenterology, Brighton, United Kingdom
P529: Adalimumab persistence and its biosimilar in inflammatory bowel disease: experience in a tertiary centreECCO'21 Virtual
Year: 2021
Authors: Fernandez Cano, M.C.(1);Sánchez-Capilla, A.D.(1);Martín-Rodríguez, M.M.(1);Cabello-Tapia, M.J.(1);Redondo-Cerezo, E.(1);
(1)Virgen de las Nieves University Hospital, Gastroenterology and Hepatology unit, Granada, Spain
P530: Proactive therapeutic drug monitoring of anti-TNF agents is associated with higher mucosal healing rates in Crohn's diseaseECCO'21 Virtual
Year: 2021
Authors: Brinar, M.(1);Sabic , M.(1);Turk , N.(1);Grgic, D.(1);Domislovic, V.(1);Cukovic Cavka, S.(1);Kozmar, A.(2);Krznaric, Z.(1);
(1)University Hospital Zagreb, Gastroenterology and Hepatology, Zagreb, Croatia;(2)University Hospital Zagreb, Clinical Institute for Laboratory Diagnosis, Zagreb, Croatia
P531: SARS-CoV-2 infection in Elderly patients with Inflammatory Bowel Disease with or without immunosuppressants during the first year of the pandemic. An observational, descriptive, cohort study.ECCO'21 Virtual
Year: 2021
Authors: Calafat Sard, M.(1,2);González-Muñoza: , C.(3); Fortuny, M.(1);Roig, C.(3);Calm, A.(1);Mombiela, A.(3);Teller-Martin, M.(3);Cañete:, F.(1,2);Bertoletti, F.(3);González-González, L.(1);Gordillo, J.(3);Mañosa, M.(1,2);Garcia-Planella , E.(3);Domènech, E.(1,2);
(1)Hospital Universitari Germans Trias i Pujol, Gastroenterology Department, Badalona, Spain;(2)Ciberehd, Ciberehd, Madrid, Spain;(3)Hospital de la Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain
P532: Delay of maintenance infliximab increases the risk of relapse in Crohn’s disease during the COVID-19 pandemicECCO'21 Virtual
Year: 2021
Authors: Guo, H.(1);Tang, J.(1);Huang, Z.(1);Li, B.(1);Yang, Q.(1);Chao, K.(1);Gao, X.(1);
(1)the Sixth Affiliated Hospital of Sun Yat-sen University, Gastroenterology, Guangzhou, China
P533: Adalimumab 80mg every other week in inflammatory bowel disease: Treatment intensification outcomes in real life clinical practiceECCO'21 Virtual
Year: 2021
Authors: Calvo Moya, M.I.(1);Omella Usieto, I.(2);El Hajra Martinez, I.(2);Santos Perez, E.(2);Gonzalez Lama, Y.(1);Ruiz Antoran, B.(3);Menchen Viso, B.(4);Matallana Royo, V.(1);Gonzalez Partida, I.(1);De Lucas Tellez de Meneses, R.(1);Bella del Castillo, P.(1);Gonzalez Rodriguez, M.(1);Vera Mendoza, M.I.(1);
(1)Hospital Universitario Puerta de Hierro - Majadahonda, IBD Unit. Gastroenterology and Hepatology, Madrid, Spain;(2)Hospital Universitario Puerta de Hierro - Majadahonda, Gastroenterology and Hepatology, Madrid, Spain;(3)Hospital Universitario Puerta de Hierro - Majadahonda, Clinical Pharmacology, Madrid, Spain;(4)Hospital Universitario Puerta de Hierro - Majadahonda, Hospital Pharmacy, Madrid, Spain
P534: Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in Russia: results of the EXPLORE studyECCO'21 Virtual
Year: 2021
Authors: Shapina, M.(1);
(1)State Scientific Centre of Coloproctology named after A.N.Ryzhih- Moscow- Russia, Gastroenterology, Moscow, Russian Federation; Authors: Abdulganieva D.I.1 Chashkova E.Y.2 Gubonina I.V.3 Schukina O.B.4 Shapina M.V.5 1Kazan State Medical University Kazan Russia 2 Irkutsk Scientific Center of Surgery and Traumatology Irkutsk Russia 3S.M. Kirov Military Medical Academy Saint-Petersburg Russia 4North-Western State Medical University named after I.I. Mechnikov Saint-Petersburg Russia 5State Scientific Centre of Coloproctology named after A.N.Ryzhih Moscow Russia
P535: Optimising vedolizumab in treatment sequences for Crohn’s disease: Results from a simulation model using real-world evidenceECCO'21 Virtual
Year: 2021
Authors: Louis, E.(1);Nikolaou, A.(2);Litkiewicz, M.(2);Agboton, C.(3);Wang, S.(4);Armuzzi, A.(5);
(1)University Hospital CHU of Liège, Department of Gastroenterology, Liège, Belgium;(2)Evidera, Modelling and Simulation, London, United Kingdom;(3)Takeda, Global Medical Affairs - Gastroenterology, Zurich, Switzerland;(4)Takeda, Global Evidence & Outcomes - Gastroenterology, Cambridge, United States;(5)Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica, Gastroenterology Unit CEMAD, Rome, Italy